January 22, 2026
1 min read

Global pharma manufacturing output surged in ’25 in ‘front-loading’ response to US tariff threats: report

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026, according to a new report from financial services firm Atradius.

Leave a Reply

Your email address will not be published.

Previous Story

Abbott drops as Nutrition unit drives Q4 revenue miss

Next Story

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes

Previous Story

Abbott drops as Nutrition unit drives Q4 revenue miss

Next Story

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes

Latest from Blog

Go toTop